Visipaque 270 mg I/ml inj. sol. i.thec./i.arter./i.v./i.cavern. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

visipaque 270 mg i/ml inj. sol. i.thec./i.arter./i.v./i.cavern. vial

ge healthcare bv-srl - iodixanol 550 mg/ml - solution for injection - 270 mg i/ml - iodixanol 550 mg - iodixanol

Visipaque 320 mg I/ml inj. sol. i.thec./i.arter./i.v./i.cavern. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

visipaque 320 mg i/ml inj. sol. i.thec./i.arter./i.v./i.cavern. vial

ge healthcare bv-srl - iodixanol 652 mg/ml - solution for injection - 320 mg i/ml - iodixanol 652 mg/ml - iodixanol

Visipaque 320 mg I/ml inj. sol. i.thec./i.arter./i.v./i.cavern. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

visipaque 320 mg i/ml inj. sol. i.thec./i.arter./i.v./i.cavern. vial

ge healthcare bv-srl - iodixanol 652 mg/ml - solution for injection - 320 mg i/ml - iodixanol 652 mg/ml - iodixanol

Visipaque 320 mg I/ml inj. sol. i.thec./i.arter./i.v./i.cavern. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

visipaque 320 mg i/ml inj. sol. i.thec./i.arter./i.v./i.cavern. vial

ge healthcare bv-srl - iodixanol 652 mg/ml - solution for injection - 320 mg i/ml - iodixanol 652 mg/ml - iodixanol

Visipaque 270 mg I/ml inj. sol. i.thec./i.arter./i.v./i.cavern. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

visipaque 270 mg i/ml inj. sol. i.thec./i.arter./i.v./i.cavern. vial

ge healthcare bv-srl - iodixanol 550 mg/ml - solution for injection - 270 mg i/ml - iodixanol 550 mg/ml - iodixanol

Visipaque 320 mg I/ml inj. sol. i.thec./i.arter./i.v./i.cavern. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

visipaque 320 mg i/ml inj. sol. i.thec./i.arter./i.v./i.cavern. vial

ge healthcare bv-srl - iodixanol 652 mg/ml - solution for injection - 320 mg i/ml - iodixanol 652 mg/ml - iodixanol

Visipaque 270 mg I/ml inj. sol. i.arter./i.cavern./i.thec./i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

visipaque 270 mg i/ml inj. sol. i.arter./i.cavern./i.thec./i.v. vial

ge healthcare bv-srl - iodixanol 550 mg/ml - solution for injection - 270 mg i/ml - iodixanol 550 mg/ml - iodixanol

Visipaque 320 mg I/ml inj. sol. i.thec./i.arter./i.v./i.cavern. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

visipaque 320 mg i/ml inj. sol. i.thec./i.arter./i.v./i.cavern. vial

ge healthcare bv-srl - iodixanol 652 mg/ml - solution for injection - 320 mg i/ml - iodixanol 652 mg/ml - iodixanol

Visipaque New Zealand - English - Medsafe (Medicines Safety Authority)

visipaque

ge healthcare limited t/a ge healthcare - medical diagnostics - iodixanol 305 mg/ml equivalent to 150 mg/ml iodine - solution for injection - 150 mg/ml - active: iodixanol 305 mg/ml equivalent to 150 mg/ml iodine excipient: calcium chloride dihydrate hydrochloric acid sodium calcium edetate sodium chloride trometamol water for injection

Visipaque New Zealand - English - Medsafe (Medicines Safety Authority)

visipaque

ge healthcare limited - iodixanol 550 mg/ml equivalent to 270 mg/ml iodine - solution for injection - 270 mg/ml - active: iodixanol 550 mg/ml equivalent to 270 mg/ml iodine excipient: calcium chloride dihydrate hydrochloric acid sodium calcium edetate sodium chloride trometamol water for injection - this medicine is for diagnostic use only. visipaque is indicated, in adult patients, for angiocardiography, peripheral arteriography, visceral arteriography, cerebral arteriography, contrast-enhanced computed tomography of the head and body, excretory urography and venography. in arteriography, visipaque may be used for both conventional radiography and digital subtraction angiography (dsa). in children, visipaque is indicated for cardioangiography, urography, ct-enhancement and studies of the upper gastrointestinal tract.